Int J Surg Case Rep
An obese patient with acute cholecystitis, nonalcoholic steatohepatitis and cirrhosis: A case report.
Zuiki T, Ohki J, Horiuchi T, Lefor AK, Shirakata F, Hirota Y, Hirota N
Laparoscopic cholecystectomy for patients with acute cholecystitis and liver cirrhosis is associated with increased risk. We present an obese patient ...
Read More
Source: PubMed
Clin Nutr 2020 Jan 22
Automated body composition analysis of clinically acquired computed tomography scans using neural networks.
Paris MT, Tandon P, Heyland DK, Furberg H, Premji T, Low G, Mourtzakis M
The quantity and quality of skeletal muscle and adipose tissue is an important prognostic factor for clinical outcomes across several illnesses. Clini ...
Read More
Source: PubMed
J. Hepatol. 2020 Jan 29
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH
Acute infection of hepatitis E virus (HEV) causes varying degrees of liver damage. Although liver-related death due strictly to HEV infection is rare ...
Read More
Source: PubMed
Metab. Clin. Exp. 2020 Jan 29
Complications, morbidity and mortality of nonalcoholic fatty liver disease.
Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health problem, affecting up to a quarter of the world's adult populatio ...
Read More
Source: PubMed
Gastroenterology 2020 Jan 29
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review.
Loomba R, Lim JK, Patton H, El-Serag HB
Nonalcoholic fatty liver disease (NAFLD) is a leading etiology for chronic liver disease with immense public health impact, affecting over 25% of the ...
Read More
Source: PubMed
